<i>RYK</i> Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients
Temozolomide (TMZ) chemotherapy is an important tool in the treatment of glioma brain tumors. However, variable patient response and chemo-resistance remain exceptionally challenging. Our previous genome-wide association study (GWAS) identified a suggestively significant association of SNP rs4470517...
Saved in:
Main Authors: | Ricardo D. Gonzalez (Author), George W. Small (Author), Adrian J. Green (Author), Farida S. Akhtari (Author), Tammy M. Havener (Author), Julia C. F. Quintanilha (Author), Amber B. Cipriani (Author), David M. Reif (Author), Howard L. McLeod (Author), Alison A. Motsinger-Reif (Author), Tim Wiltshire (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients
by: Ricardo D. Gonzalez, et al.
Published: (2023) -
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines
by: Alison A. Motsinger-Reif, et al.
Published: (2017) -
MEOX2 promotes glioma growth and temozolomide chemoresistance
by: Tengfei Li, et al.
Published: (2024) -
Optimization of Nonlinear Dose- and Concentration-Response Models Utilizing Evolutionary Computation
by: Andrew L. Beam, et al.
Published: (2011) -
Nonlinear Dose-Response Modeling of High-Throughput Screening Data Using an Evolutionary Algorithm
by: Jun Ma, et al.
Published: (2020)